Top 5 Stocks to Buy Now
→ The Treasury just bought its own debt (From Golden Portfolio) (Ad)tc pixel
LON:TSTL

Tristel Interim Earnings Report

Tristel logo
GBX 390.56 +0.56 (+0.14%)
As of 11:57 AM Eastern
ProfileEarnings HistoryForecast

Tristel EPS Results

Actual EPS
GBX 9.36
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Tristel Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tristel Announcement Details

Quarter
Interim
Date
3/2/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Tristel Earnings Headlines

Tristel (LON:TSTL) Shares Pass Above Fifty Day Moving Average - Here's Why
June 23 at 4:27 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30856565
Tristel to Outline Strategy at ShareSoc Growth Event in Leeds
May 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TSNLF/pressreleases/834952/tristel-to-outline-strategy-at-sharesoc-growth-event-in-leeds/
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
June 24 at 1:00 AM  |  Porter & Company (Ad)
Audited Preliminary Results
April 21, 2026  |  lse.co.ukhttps://www.lse.co.uk/rns/audited-preliminary-results-8gy4vsf23e2zxef.html
Artemis Takes 3% Stake in Infection Prevention Group Tristel
April 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/artemis-takes-3-stake-in-infection-prevention-group-tristel?utm_source=marketbeat.com&utm_medium=referral
Tristel Director’s Associate Increases Stake in Infection Prevention Specialist
March 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/tristel-directors-associate-increases-stake-in-infection-prevention-specialist?utm_source=marketbeat.com&utm_medium=referral
See More Tristel Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tristel? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tristel and other key companies, straight to your email.

About Tristel

Tristel (LON:TSTL) is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com

View Tristel Profile
Earnings Tools